How to raise efficacy of gastroesophageal reflux disease treatment


Cite item

Full Text

Abstract

Aim. To specify dysfunction of the stomach and duodenum in gastroesophageal reflux disease (GRD) to offer more effective pathogenetic pharmacotherapy of GRD.
Material and methods. Fibroesophagogastroduodenoscopy with further assessment of esophageal mucosa condition by Savary-Miller, intragastric pH-metry, dynamic gastroscintigraphy and electrogastrography were made in 150 GRD patients.
Results. GRD patients were found to have significant disturbances of a motor-evacuatory function of the gastroduodenal complex. Addition of domperidon and mebeverin to routine combined treatment of GRD raises clinical efficacy of GRD treatment and promotes recovery of gastric and duodenal function though therapeutic efficacy of the above drugs depended on concomitant pathology.
Conclusion. Domperidon and mebeverin addition to combined treatment of GRD makes this treatment more effective.

About the authors

Yakov Maksimovich Vakhpushev

Ижевская государствення медицинская академия

проф., зав. кафедрой пропедевтики внутренних болезней; Ижевская государствення медицинская академия

L O Potapova

O V Mupavtseva

Ya M Vakhrushev

L O Potapova

O V Muravtseva

References

  1. Ficher R. S., Ogorek C. P. Management of gastroesophageal reflux disease. Part one: Pathogenesis, symptoms and diagnosis. Pract. Gastroenterol. 1994; 6: 487-491.
  2. Hetzel D. Acid pump inhibitors. The treatment of gastroesophageal reflux. Aust. Fam. Physician 1998; 6: 487-491.
  3. Katzka P. A. Digestive system disorders. Gastroesophageal reflux disease. West. J. Med. 2000; 173: 48-53.
  4. Siegl A., Mayr J., Huber J., Urey E. Postprandial tahygastria is frequent in infants with gastroesophageal reflux. Pediatr. Surg. Int. 1998; 13: 560-571.
  5. Kahrilas P. J., Shi G., Manka M. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000; 118: 688-695.
  6. Пасечников В. Д. и др. Желудочные дизритмии как фактор риска развития гастроэзофагеальной рефлюксной болезни. Гастроэнтерол. Санкт.-Петербурга 2004; 2-3: 134.
  7. Циммерман Я. С., Телянер И. И. Синдром хронической дуоденальной непроходимости. Клин. мед. 2000; 6: 4-10.
  8. Вахрушев Я. М., Потапова Л. О. Способствующие факторы и некоторые патогенетические механизмы при гастроэзофагеальной болезни. Сиб. журн. гастроэнтерол. и гепатол. 2004; 18: 32-34.

Copyright (c) 2009 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies